C. difficile
Acurx Pharmaceuticals announces positive data from phase 2b trial for C. difficile infection treatment
October 3, 2023Research and Development Acurx Pharmaceuticals, C. difficile, Infections and infestations, clinical trial, infection
Acurx Pharmaceuticals has announced that it has discontinued its phase 2b clinical trial of its lead antibiotic candidate, ibezapolstat, for …
Drop in prescriptions for antibiotic leads to fewer cases of superbug in Wales
August 20, 2019Manufacturing and Production AMR, Antibiotics, C difficile, C. difficile, pharma, superbug
Cuts to the number of prescriptions for antibiotics have led to a drop in the number of cases of the …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
AI: an early warning system for patient safety
November 3, 2026
Highlighting the value of lab research for healthcare innovation
November 2, 2026
